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Abstract
Respiratory infections with Burkholderia cepacia complex (Bcc) bacteria in cystic fibrosis (CF) are associated with a
worse prognosis and increased risk of death. In this work, we assessed the virulence potential of three B.
cenocepacia clonal isolates obtained from a CF patient between the onset of infection (isolate IST439) and before
death with cepacia syndrome 3.5 years later (isolate IST4113 followed by IST4134), based on their ability to invade
epithelial cells and compromise epithelial monolayer integrity. The two clonal isolates retrieved during late-stage
disease were significantly more virulent than IST439. Proteomic profiling by 2-D DIGE of the last isolate recovered
before the patient’s death, IST4134, and clonal isolate IST439, was performed and compared with a prior analysis of
IST4113 vs. IST439. The cytoplasmic and membrane-associated enriched fractions were examined and 52 proteins
were found to be similarly altered in the two last isolates compared with IST439. These proteins are involved in
metabolic functions, nucleotide synthesis, translation and protein folding, cell envelope biogenesis and iron
homeostasis. Results are suggestive of the important role played by metabolic reprogramming in the virulence
potential and persistence of B. cenocepacia, in particular regarding bacterial adaptation to microaerophilic conditions.
Also, the content of the virulence determinant AidA was higher in the last 2 isolates. Significant levels of siderophores
were found to be secreted by the three clonal isolates in an iron-depleted environment, but the two late isolates were
more tolerant to low iron concentrations than IST439, consistent with the relative abundance of proteins involved in
iron uptake.
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Introduction
Long-term respiratory infections with Burkholderia cepacia
complex (Bcc) bacteria in cystic fibrosis (CF) patients generally
lead to an accelerated decline in lung function and, in many
cases, to a fatal necrotizing pneumonia known as cepacia
syndrome [1,2]. These bacteria are serious opportunistic
pathogens and virtually impossible to eradicate from the CF
lung [1,3,4]. Moreover, Bcc species are characterised by
remarkable genome plasticity, providing them with a major
advantage to adapt to the highly stressful CF lung environment
[5–7]. Widespread positive selection pressure across the
genome of Bcc bacteria leads to the emergence of multiple
phenotypic clonal variants that exhibit different antimicrobial
susceptibility patterns, as well as other phenotypic alterations
relevant in the context of bacterial pathogenesis [8–11].
Understanding the underlying mechanisms employed by Bcc
bacteria to adapt to the CF airway environment under such
conditions is crucial to deal with chronic infections and improve
disease management. We have recently contributed to the
elucidation of these adaptive mechanisms based on extensive
phenotypic, genotypic and genome-wide expression analysis of
selected B. cenocepacia clonal variants [7,8,12,13]. These are
part of an extensive collection comprising over 700 clinical
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isolates of different Bcc species, gathered during an 18-year
long epidemiological survey of Bcc bacteria involved in
respiratory infections at the major Portuguese CF Treatment
Centre at Santa Maria Hospital in Lisbon [7,14,15]. Recent
studies have focused on a series of 11 B. cenocepacia clonal
isolates (recA lineage III-A) retrieved from the sputum of a
chronically colonised CF patient (J), from the onset of infection
to his death 3.5 years later with cepacia syndrome, where
clonal expansion of the first isolate was proposed to occur
[8,14]. Three isolates from the set of 11 variants have been
particularly scrutinised by genome-wide expression analyses
[12,13]: IST439, the first B. cenocepacia isolate recovered,
which presumably initiated the infection; IST4113, obtained
almost 3 years later after a period of exacerbated infection and
intravenous therapy; and IST4134, the last isolate retrieved
from the patient immediately before death with cepacia
syndrome.
The study of mechanisms and dynamics of microbial
evolution within a host environment, and how it relates to
pathogenicity and virulence, is currently a topic of paramount
importance in health sciences. In this study, we examined the
epithelial interactions of clonal isolates IST439, IST4113, and
IST4134, and found that the 2 isolates retrieved during late-
stage disease have a significantly greater capacity for epithelial
invasion than the one recovered at the onset of infection. In an
effort to identify mechanisms underlying this altered virulence
phenotype, we employed a 2-D Difference Gel Electrophoresis
(2-D DIGE) quantitative proteomics approach, under the
assumption that proteins that are similarly altered in both
IST4113 and IST4134 compared to IST439 are likely to be
involved in the increased persistence of those clonal isolates in
the CF lung. To this end, we compared the proteomes of
IST439 and IST4134 (this work) and integrated these findings
with the prior analysis of IST4113 vs. IST439 [13], which had
been mainly focused on the identification of mechanisms of
genetic adaptation leading to antimicrobial resistance in the CF
airways. The results highlight the involvement of proteins
associated with metabolic functions in increased persistence
and virulence potential, in agreement with recent genome-wide
studies [16–18].
Materials and Methods
Burkholderia cenocepacia isolates and growth
conditions
The three clinical B. cenocepacia isolates studied, IST439,
IST4113 and IST4134, were recovered from the sputum of a
CF patient under surveillance at the CF Centre of Hospital de
Santa Maria [7,14,15]. The clonal isolates were obtained
between January 1999 and July 2002. Studies involving the
use of these isolates were approved by the ethics committee of
the Hospital (Comissão de Ética para a Saúde do HSM/FML),
and the anonymity of the patients is preserved. No unpublished
clinical data is included in this study. Studies regarding
retrospective molecular microbiology analyses and functional
genomics were authorized by the ethics committee. The
specific samples used in this study have also been described in
previous publications [7,14,15]. For the proteomic analysis, cell
samples of B. cenocepacia isolates were prepared by
suspending well isolated colonies from Luria Bertani (LB, Difco,
Sparks, MD USA) agar plates in 3 mL LB broth, followed by
overnight growth at 37°C with shaking at 250 rpm. These
cultures were used to obtain cells in mid-exponential phase
(OD640 nm of 0.4±0.05). After dilution to a standardised OD640 nm
of 0.2 in NaCl 0.9% (w/v), 100 µL of these cell suspensions
were plated onto LB agar plates and incubated for 24 hours at
37°C.
Transepithelial resistance of bronchial epithelial
monolayers exposed to B. cenocepacia clonal variants
Polarized epithelial monolayers were established using two
independent bronchial epithelial cells, which expressed
functional CFTR (16HBE14o-) or were homozygous negative
for the ΔF508 mutation (CFBE41o-) (a generous gift from Dr.
Dieter Gruenert, University of California, San Francisco).
16HBE14o- cells [19] were seeded onto 0.3 µM permeable
filter supports at a density of 1×105 cells per mL with a liquid/
liquid interface for 6 days. CFBE41o- cells (CFTR negative)
[20,21] were seeded onto 0.3 µM filters at a density of 7×105
cells per mL with a liquid/liquid interface for one day and
changed to air/liquid interface for five days. On day five,
antibiotic was removed from media and transepithelial
resistance (TER) measurements taken using electrodes (World
Precision Instruments), to confirm monolayer integrity. Bacterial
strains were grown in MM9 media and on day 6, the bacteria
were added to the epithelial monolayers at a Multiplicity of
infection (MOI) of 50:1. The TERs of both control (either no
bacteria added to the culture or Escherichia coli-exposed
monolayers) and B. cenocepacia-exposed monolayers were
measured at 0, 2, 4, 6, 8, 12 and 24 hours. TER was calculated
as follows: (Resistance of cells on filter – resistance of blank
filters) × 1.13 cm2.
Data represents the average of three separate experiments
and error bars represent the standard error of the mean.
Statistical analysis was carried out using a one-way ANOVA
and Holms-Sidak post-test.
Invasion of B. cenocepacia sequential clonal variants
into human lung epithelial cells
CFBE41o- (CFTR negative) and 16HBE14o- (CFTR
expressing) cells were seeded into 24 well plates at a density
of 4×105 cells per well in antibiotic free media for 24 hours at
37°C in a 5% CO2 humidified atmosphere. Medium was
removed and cells were washed three times with Phosphate
Buffered Saline (PBS). Strains were grown overnight in LB
media and 4×105 CFU/mL were added to Minimum Essential
Medium (MEM) alone. The bacterial cultures were added to the
wells at an MOI of 10:1 and the plate was centrifuged at 700g
for five minutes to allow bacterial interaction/ attachment to
epithelial cells. Cells and bacteria were incubated for two hours
to allow invasion. The supernatant was replaced with 1 mL of a
highly inhibitory (2 mg/mL) ciprofloxacin solution and incubated
for a further two hours to kill the extracellular bacteria. Cells
were washed three times vigorously with PBS and 500 µL of
cell lysis buffer (PBS, 10 mM EDTA, 0.25% (w/v) Triton X-100)
was added for 20 min. at room temperature. The resulting
B. cenocepacia Proteomics during Lung Infection
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lysate was serially diluted in Ringer’s solution and quantified by
viable counts on LB agar after 48 hours.
The effectiveness of the antibiotic treatment in killing the
extracellular bacteria was confirmed by plating the cellular
washes following antibiotic treatment onto LB agar plates and
incubating for 48 hours. No growth was detected on these
plates. Data represents the average of three separate
experiments and error bars represent the standard error of the
mean. Statistical analysis was carried out using a one-way
ANOVA and Holms-Sidak post-test.
Quantitative proteomic analysis based on 2-D DIGE
A 2-Dimensional Difference Gel Electrophoresis (2-D DIGE)
quantitative proteomic approach was used to compare the
cytoplasmic and the membrane-associated protein enriched
fractions of B. cenocepacia clinical isolates IST439 and
IST4134. The analysis was performed as previously described
[13]. As before, bacterial cells were harvested from solid LB
agar plates instead of planktonic cultures, because growth on
the solid agar surface is believed to be a more accurate
reflection of the physiological conditions experienced by B.
cenocepacia in the airways of CF patients. Briefly, cells were
washed from 8 LB-agar plates for each B. cenocepacia isolate,
independently prepared, with 0.9% NaCl and resuspended in
lysis buffer (10 mM Tris base, 100 mM sucrose HaltTM protease
inhibitors cocktail (Pierce, Rockford, USA)). Cell disruption was
carried out by sonication and the supernatant (crude extract)
was fractionated into cytoplasmic and membrane-associated
protein fractions by ultracentrifugation at 100,000g, during 90
min., at 4°C. The supernatant obtained was enriched in the
cytoplasmic protein fraction while the pellet corresponded to
the membrane-associated protein enriched fraction. The
membrane-associated protein fraction was washed twice with
lysis buffer followed by a second ultracentrifugation (100,000g,
60 min., 4°C) to reduce cytoplasmic protein contaminants. The
membrane-associated protein fraction was resuspended in
lysis buffer containing 2% dodecylmaltoside. Protein
concentration in the extracts was quantified using a
Bicinchoninic Acid quantification kit (Pierce), and 50 µg aliquots
of the protein samples were subjected to a clean-up process
with the 2-D Clean-up kit (GE Healthcare, Uppsala, Sweden).
Fluorescent labelling of proteins with Cy-dye™ (GE
Healthcare), isoelectric focusing (IEF), protein separation by
molecular weight, gel scanning and analysis, and preparation
of gels for posterior protein identification, were also performed
as previously described [13]. The software package Progenesis
Samespots (Nonlinear Dynamics) was used to automatically
detect protein spots and normalise individual spot volumes
against total spot volumes for a given gel. Average normalised
levels for each isolate were then compared using one-way
ANOVA between-group test. Only statistically significant spots
(P < 0.05) were selected for analysis. Differential expression
between isolates IST439 and IST4134 was determined and a
threshold of at least a 1.5-fold increase or 0.67-fold decrease
between averaged gels was considered. Spots that showed
evidence of saturation were not further analysed. The results
represent two independent growth experiments and three
technical replicates, in a total of six replicates per sample.
Identification of protein spots of interest was performed by
mass spectrometry (MS) in the proteomic unit at Centro
Nacional de Investigaciones Cardiovasculares Carlos III,
Madrid, Spain (CNIC Foundation), as detailed before [13]. The
classification into functional categories was performed using
the Burkholderia Genome Database (http://
www.burkholderia.com) [22], TIGR database (http://
www.tigr.org/), the Role Category Lists, KEGG database (http://
www.genome.jp/kegg/) and NCBI (http://
www.ncbi.nlm.nih.gov/). The mRNA levels of a randomly
selected set of genes, encoding proteins with altered
expression among the different isolates, were also determined
to reinforce the proteomic results (data not shown).
Siderophore production
Siderophore production by the three isolates under various
iron concentrations was measured using the Chrome Azurol S
(CAS) assay [23]. Briefly, bacterial supernatants were filtered
using 0.22 µM filters to remove cells. 500 μL of cell-free
supernatant was mixed with 500 μL CAS solution (150 μM
CAS, 15 μM FeCl3, 0.5 M Piperazine, 1.2 mM HDTMA) (Sigma)
and 10 µL shuttle solution (0.2 M 5-Sulfosalicylic acid) (Sigma)
and incubated for 5 hours at room temperature. Reference
samples of bacterial growth medium containing the relevant
concentration of iron were also assayed. Absorbance was
measured at 630 nm using MM9 alone as a blank. The
percentage siderophore units were calculated as [(Ar - As)/Ar]
× 100 where Ar is the absorbance of the reference and As is
the absorbance of the sample.
Results
IST4113 and IST4134 exhibit a higher capacity for
epithelial cell invasion and disruption of epithelial
monolayer integrity compared with isolate IST439
To compare the virulence potential of the three B.
cenocepacia clonal isolates retrieved during chronic infection
examined in this study, polarized epithelial monolayers were
separately exposed to isolates IST439, IST4113 and IST4134,
and epithelial integrity was analysed. B. cenocepacia IST439
was the first isolate recovered from the patient and is believed
to have initiated the infection, while IST4134 was recovered 42
months after the isolation date of IST439 and 9 months after
IST4113, immediately before the patient’s death with cepacia
syndrome and following progressive deterioration of pulmonary
function [8,13,24]. Isolate IST439 significantly reduced the
transepithelial resistance (TER) of 16HBE14o- (CFTR
expressing) monolayers after 8 hours (30%), whereas IST4113
and IST4134 both had a similar impact on TER values as early
as 4 hours (Figure 1A). In addition, both IST4113 and IST4134
continued to decrease TER values in 16HBE14o- cells to 10%
of controls (cells with no bacteria and with Escherichia coli
added) over 12 hours (P ≤ 0.001) (Figure 1A). In the
independent CFBE41o- epithelial monolayers that do not
express functional CFTR, all three isolates rapidly disrupted
tight junction integrity to 70% of controls in the first 2 hours with
no significant difference between isolates (Figure 1A).
Furthermore, there was a more rapid drop in TER in these
B. cenocepacia Proteomics during Lung Infection
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epithelial monolayers compared to the independently derived
16HBE14o- cells which express functional CFTR upon initial
exposure to the bacterial strains (Figure 1A).
Remarkably, the results on epithelial invasion also follow the
same trend: the later isolates are significantly more invasive
than IST439 using either CFTR-positive or CFTR-negative
cells, but their virulence potential varies with the type of
epithelial cells studied (Figure 1B). While IST4134 achieves a
percentage of cellular invasion that is twice that of IST4113 in
16HBE14o- (CFTR expressing) cells, IST4113 is more invasive
of CFBE41o- epithelial cells than IST4134 (Figure 1B).
Interestingly, it should be noted that CFBE41o- cells, which
carry the CF mutation, are significantly more resistant to
invasion by IST4134 (uptake of this isolate is reduced by more
than half), while the levels of invasion by the first two isolates
are comparable for both CFTR-negative and CFTR-positive
cells (Figure 1B).
Differential protein expression profile of IST4134
compared to IST439
Using a 2-D DIGE-based quantitative proteomic approach, it
was possible to identify major functional groups and cellular
functions that are altered in isolate IST4134 compared with
IST439. This analysis allowed the separation of around 740
and 850 protein spots in the gels prepared from cytoplasmic
and membrane-associated protein fractions, respectively,
within a pI range spanning from pH 3 to approximately pH 9, of
which 281 protein spots were positively identified by mass
spectrometry (Table S1). GRAVY values (grand average of
hydropathicity index) were obtained using the software
program ProtParam tool [25,26]. Positive GRAVY values are
recognised as valid indicators of hydrophobicity and of
membrane involvement [27–29]. In total, 16 (20%) of the 80
proteins identified in the membrane-associated protein fraction
had positive GRAVY values ranging from +0.273 to +0.006.
Together, the GRAVY index, the transmembrane mapping and
the subcellular localisation predictions [13] revealed an
enrichment of proteins with a hydrophobic nature in the
membrane-associated fraction.
Overall, 72 protein spots were found to have a different
content (fold-change cut-off: 1.5-fold increase or 0.67-fold
decrease; P ≤ 0.05, ANOVA) between isolates IST4134 and
IST439. Sixty-one of these protein spots, corresponding to 52
different proteins, overlapped the 89-protein dataset previously
Figure 1.  Measure of transepithelial resistance and epithelial cell invasion for B.  cenocepacia clonal isolates.
(A) Effect of B. cenocepacia clonal variants IST439, IST4113 and IST4134 on tight junction integrity of 16HBE14o- (CFTR positive)
and CFBE41o- (CFTR negative) cells. (B) Invasion potential of the three B. cenocepacia clonal variants into 16HBE14o- and
CFBE41o- epithelial cells. Data represents the mean of 3 individual experiments and error bars represent the standard error of the
mean. * P<0.01.
doi: 10.1371/journal.pone.0083065.g001
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reported for the comparison between IST4113 and IST439 [13].
All 52 proteins were altered in the same direction in both
isolates (Table 1 and Table S1). This subset of proteins will be
given a particular emphasis in light of its potential involvement
in the enhanced virulence potential and persistence of the last
two isolates.
Best-hit homologs to B. cenocepacia J2315 genes were
found for all proteins identified in the comparison between
IST4134 and IST439, with the exception of the ABC
transporter-related protein A9AH88, with 97% of identity to the
L-glutamate ABC transporter ATP-binding protein encoded by
gene Bcen_0189 from B. cenocepacia AU1054, a strain that
was recovered from the blood of a CF patient [30] (Table 1).
Proteins that were suggested to be differently expressed in
both IST4113 and IST4134, compared with IST439, were
clustered into functional categories (Table 1 and Figure 2).
Considering only the analysis of IST4134 vs. IST439, the most
prominent category is “Energy metabolism” (n = 19 proteins;
Table 1 and Figure 2), similarly to what was previously
described for IST4113 [13]. The second main category is
“Translation”, including a total of 10 proteins (9 of which are
over-expressed) with altered content in IST4134. “Cell
envelope biogenesis”, “Amino acid metabolism” and
“Nucleotide metabolism” follow, each comprising 5 proteins
with altered content in IST4134. The categories “Protein
folding” and “Iron transport” are noteworthy since all proteins
that were considered altered in IST4134 are over-expressed
compared to IST439. A more detailed description of the main
results of this quantitative proteomic analysis can be found
below.
Proteomic differences between IST4113 and IST4134
detected indirectly
Based on the fold-change ratios determined for each protein
spot in the comparison of IST4134 vs. IST439 [13] and
IST4134 vs. IST439 (Table 1), we were able to determine
indirect proteomic differences between IST4134 and IST4113,
with possible relevance to understand disease progression.
Considering a cut-off of 1.5-fold increase or 0.67-fold decrease
in IST4134 (P < 0.05) 40 proteins are altered significantly from
IST4113 to IST4134 (Table 1). Considering a more significant
fold-change cut-off (2-fold increase or 0.5-fold decrease), 9
proteins were singled-out, including the heat shock chaperone
ClpB, the C. elegans virulence factor GatA, the nucleotide
metabolism protein PurH, and 2 proteins involved in cell
envelope biogenesis, BCAL2783 (lipid synthesis) and the
assembly factor YaeT – all with reduced content in IST4134 vs.
IST4113.
The content of proteins involved in purine and
pyrimidine synthesis is higher in isolate IST4134
compared to IST439
In general, proteins involved in the de novo purine synthesis
pathway, namely PurM, PurH and GuaB, exhibit a higher
content in the later isolates than in IST439 [13] (Table 1). The
exception is PurA, an adenylosuccinate synthetase that
catalyses the first step of the conversion of inosinate into
adenosine monophosphate (AMP) in the aforementioned
pathway. This protein is less abundant in IST4134 than in
IST439 (Table 1), as previously described for IST4113 [13].
The higher content of proteins involved in the alternative step
that converts inosinate into guanosine monophosphate (GMP),
in particular GuaB, in both IST4113 and IST4134, reinforces
the previously suggested preference for the synthesis of GTP
versus AMP in both isolates, compared to IST439 [13]. The
content of proteins involved in pyrimidine synthesis is also
increased in both IST4113 and IST4134 (Table 1), in particular
CarB, one of the two subunits of the first enzyme involved in
this anabolic pathway [31].
Proteins involved in translation and protein folding
have a higher content in IST4134 compared to IST439
A total of 9 proteins involved in translation processes were
found to have a higher content in isolate IST4134, compared to
IST439, including components of the ribosome (RpsA, 3 spots,
with fold-changes ranging from 2.0 to 2.5), elongation factors
(Tuf and FusA), and tRNA synthetases (LeuS, PheT, AlaS,
ArgS, GatA and IleS) (Table 1). The content of all these
proteins is also altered in the highly antimicrobial resistant
isolate IST4113, compared to IST439 [13] (Table 1). Overall,
the results indicate that translation is more active in IST4134
than in the isolate that initiated the infection, as suggested
previously for IST4113 based on transcriptomic and proteomic
data [12,13].
The content of several proteins belonging to the category
“Protein folding” is higher in IST4134 than in IST439, including
the chaperone protein DnaK, the heat shock protein ClpB, and
the trigger factor Tig (Table 1). DnaK was described in the
Gram-negative human pathogen Brucella suis as playing an
essential role in the protein repair system that protects the
bacteria from the environment in the macrophage phagosome
[32]. Of the 72 protein spots whose content is altered in isolate
IST4134 compared to IST439, the most significantly altered
protein is ClpB, identified in two different spots (Table 1).
The content of proteins involved in cell envelope
biogenesis is altered in isolate IST4134 compared to
IST439
Proteins involved in lipopolysaccharide (LPS) biosynthesis,
namely the phosphomannomutase ManB and the NAD-
dependent epimerase, were found to have a lower content in
the last isolate compared to IST439, as previously described
for IST4113 [13] (Table 1). ManB is involved in lipid A synthesis
while the NAD-dependent epimerase protein is mainly involved
in the synthesis of core oligosaccharide and O-antigen, which
are components of the lipopolysaccharide molecule. Both
forms of the outer membrane protein assembly factor YaeT,
which is involved in protein extrusion to the outer membrane
maintaining a homeostatic LPS to protein ratio [33,34], have a
higher content in isolate IST4134 than in IST439.
Late isolates exhibit an increased content of iron
uptake proteins and are able to capture iron more
efficiently from the environment
Four proteins involved in iron uptake are more abundant in
IST4134, compared to IST439 (Table 1). Three of these are
B. cenocepacia Proteomics during Lung Infection
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Table 1. Relative fold-change of normalised protein spot intensities in 2-D DIGE gels corresponding to the cytoplasmic
(spots 1-200) and to the membrane-associated (spots 201-281) enriched fractions of B. cenocepacia clonal isolates IST4113
[13] and IST4134 (this work) compared with IST439, and IST4134 compared with IST4113, using a fold-change cut-off of 1.5
(increased content) or 0.67 (decreased content).
     Fold-Change  
Spot No.UniProtKB best hit J2315 homolog gene Gene Name Protein Function 4113 4394134 4394134* 4113 ANOVAa
 Nucleotide metabolism
3 Q1BXD4 BCAL1262 carB Carbamoyl phosphate synthase large subunit 2.2 1.6 0.7 0.008
33 A2VSP0 BCAL3261 purM Phosphoribosylaminoimidazole (AIR) synthetase 2.3 1.5 0.7 <0.001
105 Q39FS0 BCAL1873 purA Adenylosuccinate synthetase 0.7 0.7 1.0 0.010
113 Q0BI80 BCAL3336 purH Bifunctional purine biosynthesis protein PurH 5.2 2.1 0.4 <0.001
115 Q1BHF2 BCAL2061 guaA GMP synthase [glutamine-hydrolyzing] 1.5 1.4 0.9 0.014
121 A4JF47 BCAL2063 guaB Inosine-5‘-monophosphate dehydrogenase 3.2 2.1 0.7 0.007
 Protein folding
2 O68191 BCAL3270 dnaK Chaperone protein DnaK 2.0 2.2 1.1 0.011
154 O68191 BCAL3270 dnaK Chaperone protein DnaK 2.1 1.4 0.7 0.012
8 A4JES5 BCAL1919 clpB ClpB heat-shock protein 6.0 2.7 0.4 <0.001
159 A4JES5 BCAL1919 clpB ClpB heat-shock protein 5.4 2.8 0.5 <0.001
29 A9AJR0 BCAL1996 clpP ATP-dependent Clp protease proteolytic subunit 0.7 0.9 1.2 <0.001
130 Q9ZFE0 BCAL3146 groEL 60 kDa chaperonin 1 1.7 1.2 0.7 0.004
176 Q0BEF5 BCAL1997 tig Trigger factor 2.6 1.9 0.7 <0.001
233 Q1BH74 BCAL1985  Putative exported isomerase 1.5 1.5 1.0 0.091
 Transcription
258 Q39KI0 BCAL0221 nusG Transcription antitermination protein nusG 0.6 0.6 1.0 0.041
 Transcriptional regulation
248 Q0BAX7 BCAL0499  Two-component regulatory system, response regulator protein 0.9 0.7 0.8 0.019
 Translation
4 Q1BZ70 BCAL3373 leuS Leucine-tRNA ligase 3.4 2.5 0.7 <0.001
7 A4JDU9 BCAL1486 pheT Phenylalanine-tRNA ligase beta subunit 3.6 1.9 0.5 <0.001
17 B2JF06 BCAL2950 rpsA 30S ribosomal protein S1 2.7 2.2 0.8 <0.001
18 B2JF06 BCAL2950 rpsA 30S ribosomal protein S1 2.3 2.0 0.8 0.003
177 B2JF06 BCAL2950 rpsA 30S ribosomal protein S1 2.4 2.5 1.1 0.032
22 Q123F6 BCAL0232 tuf Elongation factor Tu 2.9 1.8 0.6 <0.001
178 Q1BX19 BCAL1416 alaS Alanine-tRNA ligase 2.9 2.0 0.7 <0.001
181 A2VV06 BCAL0679 argS Arginine-tRNA ligase 2.9 1.7 0.6 <0.001
183 Q1BSL2 BCAL0484 gatA Glutamyl-tRNA (Gln) amidotransferase subunit A 4.1 2.2 0.5 <0.001
186 Q1BRU5 BCAL0231 fusA Elongation factor G1 2.5 1.7 0.7 <0.001
187 A4JH32 BCAL2724 ileS Isoleucine-tRNA ligase 2.5 1.8 0.7 <0.001
190 Q0BE16 BCAL2090 tsf Elongation factor Ts 2.3 1.4 0.6 <0.001
256 Q1BT08 BCAL0630  Putative uncharacterized protein 0.5 0.6 1.4 0.017
 Amino acid metabolism
16 Q1BHV4 BCAL2213  Oligopeptidase A 2.5 1.4 0.6 0.009
36 Q39BX5 BCAL0496 argB Acetylglutamate kinase 1.6 1.1 0.7 0.002
37 Q39BX5 BCAL0496 argB Acetylglutamate kinase 2.4 1.3 0.6 <0.001
52 A2VXX6 BCAL1874 hisZ ATP phosphoribosyltransferase regulatory subunit 2.2 1.7 0.8 <0.001
90 Q1BGN7 BCAL1796  Putative saccharopine dehydrogenase 0.7 0.8 1.1 0.001
96 Q1BGN7 BCAL1796  Putative saccharopine dehydrogenase 0.7 0.8 1.1 0.027
143 A0AXU0 BCAM0512  Putative aminotransferase 2.5 1.6 0.6 <0.001
153 A2VTH5 BCAL0312 hisD Histidinol dehydrogenase 1.5 1.2 0.8 0.005
243 Q1BHV9 BCAL2221  Putative prolyl oligopeptidase 1.2 2.7 2.3 0.076
255 A2VU73 BCAL0147 metF 5,10-methylenetetrahydrofolate reductase 0.5 0.5 1.0 0.046
270 A2VSL1 BCAL3197 glyA1 Serine hydroxymethyltransferase 0.7 0.9 1.3 0.047
277 A4JGW1 BCAL2641  Putative ornithine decarboxylase 0.4 0.4 1.0 0.016
 Cell envelope biogenesis
15 A2W339 BCAM2430  Putative biotin carboxylase 2.0 1.4 0.7 0.025
35 A2VT63 BCAL3460 ddl D-alanine-D-alanine ligase 2.0 1.4 0.7 <0.001
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Table 1 (continued).
     Fold-Change  
Spot No.UniProtKB best hitJ2315 homolog geneGene NameProtein Function 4113 4394134 4394134* 4113ANOVAa
44 A2VT78 BCAL0409 paaF Putative phenylacetic acid degradation enoyl-CoA hydratase PaaF 0.7 0.8 1.1 0.010
149 A2VVY4 BCAL2783  Putative cyclopropane-fatty-acyl-phospholipid synthase 3.1 1.5 0.5 <0.001
156 A2VWW0 BCAL2284 acoE Acetyl-CoA synthetase 1 1.9 1.3 0.7 <0.001
167 A2VT29 BCAL3420 accB Acetyl-CoA carboxylase biotin carboxyl carrier protein subunit 0.6 0.8 1.3 0.008
198 Q13XC7 BCAL2080 fabZ (3R)-hydroxymyristoyl-(acyl carrier protein) dehydratase 0.7 0.9 1.3 0.044
201 A2VXD7 BCAL2083  Outer membrane protein assembly factor YaeT 4.7 2.0 0.4 0.018
242 A2VXD7 BCAL2083  Outer membrane protein assembly factor YaeT 1.2 1.7 1.4 0.075
212 A2VQ60 BCAL1829  Putative outer membrane protein 1.6 2.0 1.3 0.084
267 B1JX22 BCAL3113 manB Phosphomannomutase 0.7 0.6 0.9 0.057
269 A4JCW7 BCAL1071  NAD-dependent epimerase/dehydratase 0.6 0.5 0.8 0.017
 Energy metabolism
9 Q59097 BCAL2209 aceE Pyruvate dehydrogenase E1 component 3.5 2.0 0.6 <0.001
155 Q59097 BCAL2209 aceE Pyruvate dehydrogenase E1 component 3.4 1.9 0.6 <0.001
160 Q59097 BCAL2209 aceE Pyruvate dehydrogenase E1 component 3.4 1.8 0.5 <0.001
10 Q0BAG3 BCAM0961 acnA Aconitate hydratase 3.0 1.9 0.6 0.008
13 A2W536 BCAL3389 tktA Transketolase 1 1.5 1.3 0.8 0.009
254 A2W536 BCAL3389 tktA Transketolase 1 0.5 0.5 1.0 0.014
38 Q1BY10 BCAL2934 etfA Electron transfer flavoprotein, alpha subunit 1.6 1.3 0.8 0.008
257 Q1BY10 BCAL2934 etfA Electron transfer flavoprotein, alpha subunit 0.5 0.7 1.2 0.002
47 A2VSX6 BCAL3366 eda KHG/KDPG aldolase 1.5 1.4 0.9 0.002
81 Q0B5L9 BCAM0042  Putative aldo/keto reductase 2.3 1.4 0.6 <0.001
87 A2VSZ8 BCAL3388 gapA Glyceraldehyde-3-phosphate dehydrogenase 1 0.7 0.8 1.2 0.094
92 A2VVT0 BCAL2839 cbbA Fructose-bisphosphate aldolase 2.1 1.3 0.6 <0.001
108 A2WDT7 BCAM0972 gltA Citrate synthase 2.3 1.3 0.6 0.001
109 B1YP46 BCAL1517 odhL Dihydrolipoyl dehydrogenase 3.0 2.4 0.8 <0.001
189 B1YP46 BCAL1517 odhL Dihydrolipoyl dehydrogenase 1.7 1.4 0.8 <0.001
112 A2W309 BCAM2468  Putative aldehyde dehydrogenase family protein 3.4 2.1 0.6 <0.001
132 A2VWQ9 BCAL2338  NADH-quinone oxidoreductase 3.6 2.4 0.6 0.002
147 A4JFY5 BCAL2179 eno Enolase 0.7 0.9 1.2 0.017
168 Q1BJZ1 BCAM2821 glcB Malate synthase G 2.6 1.3 0.5 <0.001
170 Q1BNJ4 BCAM1581 pckG Phosphoenolpyruvate carboxykinase 3.8 2.2 0.6 <0.001
171 Q1BNJ4 BCAM1581 pckG Phosphoenolpyruvate carboxykinase 3.9 2.2 0.6 <0.001
204 A2VZR7 BCAM0969 sdhA Succinate dehydrogenase flavoprotein subunit 1.5 1.8 1.2 0.099
205 A2VZR7 BCAM0969 sdhA Succinate dehydrogenase flavoprotein subunit 1.6 1.7 1.1 0.040
238 A2VZR7 BCAM0969 sdhA Succinate dehydrogenase flavoprotein subunit 1.1 0.5 0.5 0.025
215 A2W2F4 BCAM2710  Putative acetyl-CoA synthetase 4.7 1.5 0.3 0.048
216 B1K5B2 BCAM1537  Putative dehydrogenase, zinc-binding subunit 1.4 1.5 1.1 0.081
227 A2VTZ2 BCAL0034 atpA ATP synthase subunit alpha 1.8 1.8 1.0 0.014
229 Q1BNJ5 BCAM1588  Isocitrate lyase 1.5 1.4 0.9 0.023
236 A2WG89 BCAM2323  Putative N-methylproline demethylase 1.3 2.2 1.7 0.086
253 Q1BRR9 BCAL0205  NADP-dependent malic enzyme 0.3 0.5 1.7 0.065
261 A2WBM9 BCAL2908 fumC Fumarate hydratase class II 0.6 0.5 0.8 0.012
262 Q1BNF8 BCAM1542  Putative aldehyde dehydrogenase 0.6 0.6 1.0 0.052
272 Q1BJI6 BCAM2702 prpC 2-methylcitrate synthase 1.3 1.7 1.7 0.055
276 A9AIN1 BCAL2074 ppsA Phosphoenolpyruvate synthase 0.5 0.5 0.5 0.016
 Iron transport
68 B1YXQ3 BCAM0026  Putative siderophore-interacting protein 3.2 1.9 0.6 0.033
202 A2W3M3 BCAM2224  Putative pyochelin receptor protein FptA 1.8 1.6 0.9 0.016
203 Q1BM21 BCAM0948  TonB-dependent receptor 1.8 1.5 0.8 0.017
240 Q1BWE3 BCAL1691 orbC Putative iron transport-related ATP-binding protein 1.0 1.5 1.5 0.010
 Intracellular trafficking and secretion
232 A2VW75 BCAL2669  Hypothetical protein 1.7 1.7 1.0 0.011
 Secondary metabolites biosynthesis
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also over-expressed in IST4113 compared to IST439: putative
siderophore-interacting protein, putative pyochelin receptor
protein FptA and TonB-dependent receptor [13]. OrbC, a
putative iron transport-related ATP-binding protein whose gene
expression is up-regulated by OrbS under iron deprivation
conditions [35], was only over-expressed in isolate IST4134,
compared to IST439 (Table 1). These results led us to examine
the production of siderophores by the three clonal variants,
using the CAS assay with different iron concentrations (Figure
3). Significant levels of siderophores were secreted by the
three B. cenocepacia isolates within two hours of exposure to
an iron-depleted environment, demonstrating the ability of this
species to rapidly adjust to low iron availability (Figure 3). The
results obtained show that IST4113 and IST4134 are more
tolerant to low iron concentrations than IST439. The latter
produces significantly higher levels of siderophores below 6 µM
of Fe3+ (Figure 3A), while isolates IST4113 and IST4134 only
up-regulate siderophore production below 5 µM or 4 µM of
Fe3+, respectively (Figure 3B, C).
Alteration of proteins involved in metabolic processes
Energy and central intermediary metabolism functions are
strikingly overrepresented among proteins whose content is
altered in IST4134, compared to IST439 (Table 1, Figure 2).
This is the case of several proteins of the tricarboxylic acid
(TCA) cycle (OdhL, AcnA, SdhA and FumC) and other
pathways like glycolysis/gluconeogenesis (Putative aldehyde
dehydrogenase family protein), pyruvate metabolism (PpsA,
AceE, OdhL and PckG), and oxidative phosphorylation (NADH-
quinone oxidoreductase, SdhA and AtpA) (Table 1). In total, 19
of the 23 protein spots that are differently abundant in isolate
IST4134 compared to IST439 are also altered in IST4113 [13]
(Table 1). However, a number of proteins with functions in cell
metabolism that were altered in IST4113 did not have their
expression altered in IST4134, or exhibited a less significant
variation.
Discussion
In this study we assessed the virulence potential of three B.
cenocepacia clonal isolates involved in a 3.5-year long chronic
Table 1 (continued).
     Fold-Change  
Spot No. UniProtKB best hit J2315 homolog gene Gene Name Protein Function 4113 439 4134 439 4134* 4113 ANOVAa
34 A2W219 BCAM0023 adc Probable acetoacetate decarboxylase 2.3 1.4 0.6 <0.001
 Coenzyme metabolism
20 A4JIQ4 BCAL0509 metK S-adenosylmethionine synthetase 0.7 0.9 1.3 0.001
69 A0K8R4 BCAL2212 folD Bifunctional protein FolD 1.6 1.4 0.9 0.026
64 A4JKF8 BCAM0022  Putative D-beta-hydroxybutyrate dehydrogenase 2.1 1.4 0.7 <0.001
 Replication
220 Q1BLY0 BCAM0904 polA DNA polymerase I 1.1 1.8 1.6 0.078
 Adaptation to atypical conditions
75 A2VVV1 BCAL2816  S-formylglutathione hydrolase 1.6 1.4 0.8 0.038
25 A2VT33 BCAL2013  AhpC/TSA family protein 0.7 1.0 1.4 0.002
252 A2VXR9 BCAL1937  Putative phosphorous metabolism-related protein 0.5 0.5 1.0 0.015
 Transport of small molecules
213 Q1BGR3 BCAL1823 potG Putrescine ABC transporter ATP-binding protein 1.2 1.8 1.5 0.077
231 A2W3K2 BCAM2247 livF Putative amino acid ABC transporter ATP-binding protein 1.5 1.4 0.9 0.019
235 A9AH88   ABC transporter related (Polar amino acid transport) 1.6 2.5 1.6 0.046
263 Q1BIT4 BCAS0242  Hypothetical protein 0.6 0.6 1.0 0.041
 Adhesion
266 Q1BKJ6 BCAM0184 bclB Lectin (Fucose-binding lectin II) 0.6 0.6 1.0 0.056
 Unknown
128 Q1BJ23 BCAS0293 aidA Nematocidal protein AidA 3.0 3.2 1.1 <0.001
131 B1KBA2 BCAS0292  Hypothetical protein 0.7 0.8 1.1 0.017
207 B1KBA2 BCAS0292  Hypothetical protein 0.8 0.7 0.9 0.043
250 A2VS76 BCAL3052  Hypothetical protein 0.8 0.7 0.9 0.015
For each protein, the Genebank accession number of the best-hit protein identified by MS and the respective J2315 homolog gene are indicated.
a Values were calculated as the average data from two independent experiments (six replicates of each sample) and data were filtered to retain spots with ANOVA P-value
lower than 0.05. In some specific cases, results with ANOVA P-value up to 0.05 are shown.
vs. IST439 and IST4134 vs. IST439. * Indirect determination based on the analysis of IST4113
The 30S ribosomal protein S2 (BCAL2091, spot 219) was used as a reference spot control, since its quantity remained constant across all replicates and strains. Individual
spot volumes were automatically normalised against the total volume for a given gel using Progenesis Samespots software.
doi: 10.1371/journal.pone.0083065.t001
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infection of a CF patient, from the onset of infection until death
with the cepacia syndrome, and explored a quantitative
proteomic analysis to uncover key mechanisms of
pathogenesis during progressive CF lung disease. Although
genome-wide expression analyses at the transcript level have
been previously applied to study B. cenocepacia virulence in a
CF context [12,30], mRNA levels do not always correlate
directly with protein levels. In spite of its lower coverage,
quantitative proteomics is an invaluable tool to supply
complementary quantitative and functional data, allowing a
more accurate understanding of the biological functions
involved.
The two isolates recovered during late-stage CF lung
disease (IST4113 followed 9 months later by IST4134,
immediately before the patient’s death) were shown to be
significantly more virulent than the clonal isolate believed to
have initiated the infection, IST439. In fact, all three isolates
were able to disrupt the integrity of 16HBE14o- (CFTR
expressing) monolayers, however the effect of IST4113 and
IST4134 was similarly swifter (4 hours vs. 8 hours for IST439),
suggesting that genetic adaptation of the initial isolate during
the course of the chronic infection led to an enhanced ability of
the last isolates to gain access to underlying tissue. Although it
could be expected that the isolate retrieved immediately before
the patient’s death (IST4134) would be more effective than
IST4113, this was not the case. It is likely that the effect of
IST4113 was maximal and could not be further augmented.
Interestingly, there were no differences between isolates in
CFBE41o- (CFTR negative) cells. The effect on monolayer
integrity was also more rapid, which may be significant in vivo.
These observations might be attributed to the tight junction
regulatory protein Zo-1. We have previously shown that Zo-1 in
CFBE41o- cells is more susceptible to disruption by Bcc
infection than in 16HBE14o- cells [36], so it is probable that the
early isolate had an optimal impact on the tight junctions of the
CFBE41o- cells which was not further disrupted by the later
isolates.
The results on invasion potential are comparable, but more
dependent on the type of epithelial cells used. The more
resistant phenotype of cells lacking a functional CFTR to
IST4134 might be correlated with our previous findings that B.
cenocepacia strain J2315 invasion was significantly reduced in
CFBE41o- cells relative to 16HBE14o- cells [36]. In fact, CFTR-
mediated cellular invasion has been described for some
pathogens including P. aeruginosa [37], and although this has
not been reported for B. cenocepacia, it may account for the
diminished levels of invasion of CFBE 41o- cells. In addition,
the absence of the CFTR receptor will change many aspects of
cellular physiology, which could potentially alter susceptibility to
invasion. Finally, it should also be noted that these are not
paired bronchial epithelial cell lines and so differences other
than the CFTR receptor will further confound comparisons of
data derived from these two cell lines. The loss of epithelial
monolayer integrity in the presence of the isolates and their
Figure 2.  Clustering of the proteins differently expressed in B.  cenocepacia clonal variants, based on biological function.
Number of proteins differently expressed in isolates IST4113 [13] or IST4134 (this work), compared to IST439, grouped by
functional categories (as detailed in Table 1), based on the information available in the Burkholderia Genome database and in the
KEGG Pathways Database. All categories that include less than 2 proteins were grouped together as “Others”; this category
includes proteins involved in “Coenzyme metabolism”, “Intracellular trafficking and secretion”, “Secondary metabolites biosynthesis”,
“Transcription” Transcriptional regulation”, “Replication”, “Adaptation to atypical conditions” and “Adhesion”.
doi: 10.1371/journal.pone.0083065.g002
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Figure 3.  Siderophore production measured by CAS assay for the three B.  cenocepacia clonal variants.
Siderophore production was measured for isolates IST439 (A), IST4113 (B) and IST4134 (C) under different iron concentrations (1
to 11 μM of Fe3+) added to minimal M9 media.
doi: 10.1371/journal.pone.0083065.g003
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ability to invade epithelial cells are two distinct bacterial host
interactions, but both potentially facilitate effective and
persistent colonisation of the lung tissue. Moreover, a
correlation between in vitro invasion of epithelial cells by B.
cenocepacia and in vivo virulence in a mouse model has
previously been demonstrated [38] and suggests that
increased epithelial invasiveness by the later isolates may have
implications for in vivo infection.
The proteomes of IST4134 and IST439 were compared
quantitatively and integrated with a previous report focusing on
the analysis of the highly antimicrobial resistant isolate
IST4113 vs. IST439 [13]. The key aim was to identify groups of
proteins and/or functions that were similarly altered in IST4113
and IST4134 and could therefore be associated with their
increased potential for tissue invasion compared with IST439.
The proteins and functions where the proteomic profiles (and
therefore the adaptive evolution) of IST4113 and IST4134
diverged were also a point of interest given its relevance to the
understanding of late-stage progression of the disease.
There is a marked similarity between the alterations in both
IST4113 and IST4134 compared to IST439, suggestive of a
convergence in the adaptive evolution of both isolates in the
lung concomitant with disease progression (IST4113 and
IST4134 were collected within 9 months of each other). Of
particular interest are the following pathways and processes: 1)
up-regulation of protein translation and folding, 2) up-regulation
of purine and pyrimidine biosynthesis, 3) LPS biosynthesis 4)
up-regulation of iron uptake and scavenging, and 5) metabolic
adaptation. Both IST4113 and IST4134 are more resistant to
antibiotics targeting protein translation [8], which is in
agreement with the increased content of proteins involved in
translation, although more marked in the highly resistant
IST4113 (Table 1). The same is observed for proteins involved
in protein folding, stabilisation or in prevention of protein
aggregation, which is likely to contribute to the adaptive
response of the colonising bacteria to the stressing conditions
of the CF airways [39–41]. The increase in nucleotide
biosynthetic activity is also suggestive of a better performance
of repair processes in the adapted isolates, which can be
induced by host defences or antimicrobial therapy [42].
Importantly, genes encoding enzymes of the purine and
pyrimidine biosynthesis pathways were recently shown to be
essential for B. cenocepacia H111 virulence in multiple non-
mammalian host models of infection [43]. Survival and growth
of bacteria in the human bloodstream is also dependent on de
novo purine and pyrimidine biosynthetic pathways [44]. Overall,
these indications propose an association between the
increased expression of purine and pyrimidine biosynthetic
pathways in IST4113 and IST4134 and their greater capacity
for tissue invasion.
The proteomes of both IST4113 and IST4134 reflect a
decreased biosynthesis of LPS or the synthesis of a modified
molecule compared to IST439. Remarkably, recent studies on
the evolution of B. cenocepacia and B. dolosa species have
unveiled a mechanism of convergent evolution involving the
gene cluster responsible for synthesising the O-antigen as well
as other LPS-related genes, both in vivo and in vitro,
highlighting a probable role of altered LPS synthesis in
adaptation and persistence [9,18]. The proteomic results also
indicate that the late-stage clonal isolates are able to capture
iron more efficiently from the environment [45]. The proteomic
analysis was corroborated by further results showing that the
later isolates are better adapted to low iron conditions, as
demonstrated by the levels of siderophores secreted under
different iron availability conditions (Figure 3B, C). This
adaptation evidenced by IST4113 and IST4134 is a relevant
mechanism that might contribute to the increased survival and
persistence of both isolates in the CF lung. Interestingly, a
recent study of experimental evolution of B. cenocepacia in
biofilms identified convergent mutations in pathways involved in
iron scavenging, suggesting that this adaptive mechanism
might be favoured by the biofilm environment rather than an
iron-limited environment [18].
Remarkably, out of 40 proteins with a significant difference
between IST4134 vs. IST4113, only 2 had a higher content in
IST4134, suggesting a general decrease in expression for all
proteins identified, in particular those involved in metabolic
pathways, such as amino acid, nucleotide and energy
metabolism. Furthermore, there are several proteins in the
latter category that are altered in IST4113 but not in IST4134
(Table 1). These results might reflect a mechanism of
metabolic reprogramming and optimisation occurring alongside
disease progression, where the bacteria continuously adjust
their metabolic requirements to the evolving host environment,
as previously seen for B. cenocepacia [46] and P. aeruginosa
[47,48]. This metabolic reprogramming that underlies several of
the alterations described above is likely an adaptation to the
nutritional and microaerobic conditions experienced by the two
later isolates in the lung of the CF patient. Recent studies are
indicative of lowered oxygen tension in the mucus of CF
patients and have shown that B. cenocepacia is well adapted
to these conditions [49]. This has also been substantiated by
reports of parallel evolution of oxygen-dependent regulatory
pathways in B. dolosa [50]. We have found that 23 proteins that
are altered in the two later isolates are also involved in the
response of B. cenocepacia J2315 to low oxygen availability
[49], encompassing protein folding, cell envelope biogenesis
and energy metabolism (e.g. fatty acid metabolism; Table S2).
These observations highlight the complexity of the CF lung
host environment, where adaptive mechanisms become
intertwined as the colonising population faces varying selective
pressures. Increases in proteins involved in the metabolism of
fatty acids have also been previously associated with
adaptation to low oxygen in P. aeruginosa isolates [48], and
are consistent with a previously proposed adaptive strategy
involving a reduction of the fatty acid saturation degree in
association with severe oxygen depletion in the CF lung [8]. It
should be noted that the clinical clonal isolates used in this
study were grown under aerobic conditions, and therefore we
were not able to identify proteins that are induced specifically
under oxygen limitation or anaerobiosis.
Although isolates IST4134 and IST4113 were found to have
greater virulence potential than IST439, only two proteins
described as virulence factors in B. cenocepacia, AidA and
GatA, were altered in the proteomes of the last two isolates
(this study and ref [13].). However, even though both proteins
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were shown to be involved in nematode pathogenicity [43,51],
the same has not been demonstrated in other infection models,
including G. mellonella, mice or rats [11,52]. For this reason, a
correlation between the different epithelial invasiveness of
these isolates and the content of these virulence factors in the
corresponding proteomes cannot be established. The absence
of other classical virulence factors might be at least partially
explained by the limited coverage of the 2-DE-based proteomic
analysis, particularly at the level of cell membrane, membrane-
associated and secretory proteins [53]. However, this is in line
with the general conclusions of recent studies using genome-
wide approaches, in particular based in the screening of mutant
libraries to identify virulence determinants [11,54,55].
Furthermore, it is also in agreement with an ongoing analysis of
the secretome of the three isolates (manuscript under
preparation) aiming to identify secreted proteins with a role in
pathogenesis [16,56]. Finally, it is also worth noting that the
culture conditions of the bacteria will undoubtedly impact on
their proteomic profile and the data may not be reflective of all
proteomic changes that occur in the competitive environment of
the host.
In conclusion, our results reinforce the idea that adaptation to
the host environment is essential for the development of
chronic infections by B. cenocepacia and cannot be dissociated
from the rapid deterioration of lung function observed during
late-stage disease [11,43,46]. Metabolic pathways are
proposed to play a crucial role in the adaptation and
persistence of B. cenocepacia in the CF lung, in line with
previous reports of gene expression alteration during chronic
CF infections with both Bcc and P. aeruginosa species [46–48].
Future work will focus on the exploitation of the different
hypotheses raised throughout this study, namely in the
verification of specific mechanisms responsible for the
increased virulence potential and ability to persist of late-stage
isolates.
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